Publicaciones

Relativas a la Línea "Marcadores diagnósticos, pronósticos y predictivos en cáncer de pulmón"

  • Ezponda T, Pajares MJ, Agorreta J, Echeveste JI, López-Picazo JM, Torre W, Pío R, Montuenga LM. The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression. Clinical Cancer Researcn 2010; 16: 4113-4125. IF: 7.338; Lugar: 16/185 Oncology. Primer decil.
    ABSTRACT CORTESÍA DE PUBMED

  • Ponz-Sarvisé M, Nguewa PA, Pajares MJ, Agorreta J, Lozano MD, Redrado Pío R, Behrens C, Wistuba I, García-Franco, CE, García-Foncillas J, Montuenga, LM, Calvo A, Gil-Bazo I. Inhibitor of differentiation-1 is a novel prognostic factor in NSCLC patients with adenocarcinoma histology and contributes to therapy resis- tance. Clinical Cancer Research 2011; 17: 4155-4166. IF: 7.742; Lugar: 14/196 Oncology. Primer decil.
    ABSTRACT CORTESÍA DE PUBMED

  • Pajares MJ, Agorreta J, Larrayoz M, Vesin A, Ezponda T, Zudaire I, Torre W, Lozano MD, Brambilla E, Bram- billa C, Wistuba, II, Behrens C, Timsit JF, Pío R, Field JK,Montuenga LMExpression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung. J Clin Oncol 2012; 30: 1129-1136. IF: 18.038; Lugar: 5/197 Oncology. Primer decil.
    ABSTRACT CORTESÍA DE PUBMED

  • Sandoval J, Méndez-González J, Nadal E, Chen G, Carmona FJ, Sayols S, Morán S, Heyn H, Vizoso M, Gómez A, Sánchez-Céspedes M, Assenov Y, Muller F, Bock C, Tarón M, Mora J, Muscarella LA, Liloglou T, Davies M, Pollan M, et alA prognostic DNA methylation signature for stage I non-small-cell lung cancer. J Clin Oncol 2013; 31: 4140-4147. IF: 17.960. Lugar: 5/203 Oncology. Primer decil.
    ABSTRACT CORTESÍA DE PUBMED

  • Ajona D, Pajares MJ, Corrales L, Pérez-Gracía JL, Agorreta J, Lozano MD, Torre W, Massion PP, de-Torres JP, Jantus-Lewintre E, Camps C, Zulueta JJ, Montuenga LM, Pío R. Investigation of complement activation product C4d as a diagnostic and prognostic biomarker for lung cancer. Journal of the National Cancer Insti- tute 2013; 105: 1385-1393. IF: 15.161. Lugar: 8/203 Oncology. Primer decil.
    ABSTRACT CORTESÍA DE PUBMED

Relativas a la Línea "Nuevas dianas moleculares en cáncer"

  • Bleau AM, Freire J, Pajares MJ, Zudaire I, Anton I, Nistal-Villan E, Redrado M, Zandueta CN, Garmendia I, Ajona D, Blanco D, Pio R, Lecanda F, Calvo A, Montuenga LM. New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations. International Journal of Cancer 2014; 135: 2516-2527. IF: 5.007. Lugar: 34/203 Oncology. Primer cuartil.
    ABSTRACT CORTESÍA DE PUBMED

  • Larrayoz M, Pio R, Pajares MJ, Zudaire I, Ajona D, Casanovas O, Montuenga LM,Agorreta J. Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype. EMBO Mol Med 2014; 6: 539-550. IF (2012): 7.795. Lugar: 9/121 Medicine, Research & Experimental. Primer decil.
    ABSTRACT CORTESÍA DE PUBMED

  • Larzabal L, de Aberasturi AL, Redrado M, Rueda P, Rodriguez MJ, Bodegas ME, Montuenga LM, Calvo. TMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis. Br J Cancer 2014; 110: 764-774. IF (2012): 5.082; Lugar: 35/197 Oncology. 1er cuartil.
    ABSTRACT CORTESÍA DE PUBMED

  • Antón I, Molina E, Luis-Ravelo D, Zandueta C, Valencia K, Ormazabal C, Martínez-Canarias S, Pajares MJ, Agorreta J, Montuenga LM, Perurena N, Wistuba II, de las Rivas J, Segura V, Hermida J, Lecanda F. Activated Protein C and its Receptor Reduce Apoptosis and Promote Tumor Metastasis in Human Lung Adenocarcinoma. American J Resp & Crit Care Medicine 2012; 186: 96-105. IF: 11.080; Lugar: 1/48 Respiratory System. Primer decil.

  • Martinez-Velez N, Xipell E, Jauregu P, Zalacain M, Marrodan L, Zandueta C, Vera B, Urquiza L, Sierrasesú- maga L, San Julián M, Toledo G, Pueyo J, Gomez-Manzano C, Torre W, Lecanda F, Patiño-García A, Alonso MM. The oncolytic adenovirus Δ24-RGD in combination with cisplatin exerts a potent  anti-osteosarcoma activity. J Bone Miner Res 2014; 29: 2287-96. IF: 6.589. Lugar: 12/124 Endocrinology and Metabolism. Primer decil.
    ABSTRACT CORTESÍA DE PUBMED



"We try to determine the mechanisms that promote carcinogenesis and metastasis of solid tumors with the goal of identifying and validating new molecular markers and therapeutic targets" , Dr. Rubén Pío, Program Director.

Contact

Contact:
Marisol Ripa
Avda. Pío XII, 55
31008 Pamplona
Spain

(+34) 948 194 700 Ext. 1010
msripa@unav.es